Octreotide implant
奥曲肽植入剂
Report date: 2023/04/19 16:58:15
Base Information
Drug NameOctreotide implant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValera Llc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEndo Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A